Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

NIH Researchers Pilot Predictive Medicine by Studying Healthy People's DNA

June 5, 2015 8:39 am | by National Institute of Health | News | Comments

A new study has turned traditional genomics research on its head. Read more...


More Reason for Calm than Panic in South Korea's MERS Scare

June 5, 2015 8:34 am | by Foster Klug, Associated Press | News | Comments

Here's a look at what's happening in South Korea. Read more...


Mylan Launches Generic Version of Seasonique Tablets

June 5, 2015 8:26 am | News | Comments

This tablet is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Read more...


FDA Panel Backs Female Libido Drug

June 5, 2015 8:20 am | by Stephanie Guzowski, Editor | News | Comments

On Thursday, the panel of advisers to the U.S. Food and Drug Administration voted 18 to 6 to recommend that the agency approve flibanserin— nicknamed ‘women’s Viagra’ — as the first prescription treatment to boost libido in women. The contingency? Read more...


Onxeo Announces New Data for Two Orphan Oncology Drugs

June 4, 2015 12:19 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Onxeo’s Chief Scientific Officer Graham Dixon spoke with Drug Discovery & Development about the development of the orphan oncology market as well as elaborated on the news related to his company’s top two drugs. Read more...


FDA Clears Roche's HSV 1 and 2 Test

June 4, 2015 11:22 am | News | Comments

Roche announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas HSV 1 and 2 Test for the direct detection and differentiation of HSV-1 and HSV-2 DNA in anogenital specimens from symptomatic patients. Read more...


Appalachia Gripped by Hepatitis C Epidemic, Bracing for HIV

June 4, 2015 11:08 am | by Claire Galofaro, Associated Press | News | Comments

Patton Couch shook his head and clenched his teeth, recounting the night four years ago when he plucked a dirty needle from a pile at a flophouse and jabbed it into his scarred arm. He knew the odds; most of the addicts in the room probably had hepatitis C. Read more...


Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says GBI Research

June 4, 2015 11:03 am | News | Comments

The active and diverse treatment pipeline for asthma boasts a striking level of innovation, with many first-in-class products representing significant investment opportunities, says business intelligence provider GBI Research. Read more...


Precision Health: Predicting and Preventing Disease — Not Just Treating It

June 4, 2015 10:59 am | by Stanford University | News | Comments

Imagine a system where doctors can quickly comb through millions of anonymized patient records to find people with conditions and medical experiences just like yours. Through this massive, searchable database, doctors could determine how best to treat you, based on what has worked effectively for others with similar symptoms and characteristics. Read more...


Researchers Home in on What's Wearing Out T Cells

June 4, 2015 10:55 am | by Penn University | News | Comments

Sometimes even cells get tired. When the T cells of your immune system are forced to deal over time with cancer or a chronic infection such as HIV or hepatitis C, they can develop "T cell exhaustion," becoming less effective and losing their ability to attack and destroy the invaders of the body Read more...

Berg: Data on BPM 31510 Solid Tumor Trial

June 4, 2015 10:16 am | News | Comments

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 – June 2 in Chicago. Read more...


Using Diamond to Identify Counterfeit Drugs

June 4, 2015 8:50 am | by Dr. Andrew S. Janoff, Founder and CEO, Taaneh, Inc. | Articles | Comments

In countries around the world, the sale of counterfeit drugs is a significant problem for the pharmaceutical industry. It is estimated that global sales of counterfeit drugs now total more than $350 billion every year. In addition to lost revenue for drug marketers, falsified drugs also pose a significant risk to the safety and well being of consumers. Read more...


Scientists Produce Strongest Evidence Yet of Schizophrenia's Causes

June 4, 2015 8:48 am | by Cardiff University | News | Comments

Researchers discover that risk mutations disrupt a delicate chemical balance in the brain, responsible for brain development and function. Read more...


Links Found Between Blood Type, Risk of Cognitive Decline

June 4, 2015 8:42 am | by University of Sheffield | News | Comments

A pioneering study has revealed blood types play a role in the development of the nervous system and may cause a higher risk of developing cognitive decline. Read more...


Takeda's Zafatek is Now Available for Treatment of Type 2 Diabetes in Japan

June 4, 2015 8:30 am | News | Comments

The approval of ZAFATEK was granted based on the safety and efficacy results of multiple clinical phase III studies in patients with type 2 diabetes in Japan. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.